Acrivon Therapeutics Price Chart
Acrivon Therapeutics Volume Chart
Acrivon Therapeutics Market Segments
Premarket
+0.00(+0.00%)
| Open | $1.56 |
|---|---|
| Close | $1.56 |
| Low | $1.56 |
| Low Change | 0.00 (0.00%) |
| High | $1.56 |
| High Change | +0.00 (+0.00%) |
| Range | $0.00 |
| Volume | 500 |
| Dollar Volume | $779.85 |
After Hours Yesterday
-0.03(-1.97%)
| Open | $1.52 |
|---|---|
| Close | $1.49 |
| Low | $1.49 |
| Low Change | -0.03 (-1.97%) |
| High | $1.52 |
| High Change | +0.00 (+0.00%) |
| Range | $0.03 |
| Volume | 981 |
| Dollar Volume | $1.46K |
Regular Trading Hours Yesterday
+0.13(+8.93%)
| Open | $1.40 |
|---|---|
| Close | $1.53 |
| Low | $1.38 |
| Low Change | -0.02 (-1.43%) |
| High | $1.55 |
| High Change | +0.15 (+10.36%) |
| Range | $0.17 |
| Volume | 360.312K |
| Dollar Volume | $549.48K |
Premarket Yesterday
-0.07(-4.93%)
| Open | $1.42 |
|---|---|
| Close | $1.35 |
| Low | $1.31 |
| Low Change | -0.11 (-7.75%) |
| High | $1.43 |
| High Change | +0.01 (+0.70%) |
| Range | $0.12 |
| Volume | 8.428K |
| Dollar Volume | $11.38K |
Acrivon Therapeutics Moving Averages
| 5 Day Moving Average (SMA5) | $1.40 |
|---|---|
| 10 Day Moving Average (SMA10) | $1.48 |
| 20 Day Moving Average (SMA20) | $1.56 |
| 50 Day Moving Average (SMA50) | $1.65 |
| 100 Day Moving Average (SMA100) | $1.97 |
| 200 Day Moving Average (SMA200) | $1.75 |
Acrivon Therapeutics Statistics
| Average Volume (30 Days) | 820.68K |
|---|---|
| P/E Ratio (Current) | -.76 |
| EPS (Current) | -$2.01 |
| Dividend Yield | 0.00% |
| Free Cash Flow | -$65.33M |
| Cash Ratio | 2.65 |
| Current Ratio | 7.69 |
| Quick Ratio | 7.69 |
| Debt to Equity | 0.00 |
| Enterprise Value | $17.39M |
| EV to EBITDA | -0.21 |
| EV to Sales | — |
| Price to Book | 0.52 |
| Price to Cash Flow | — |
| Price to Free Cash Flow | — |
| Price to Sales | — |
| Return on Assets | -0.60% |
| Return on Equity | -0.69% |
Acrivon Therapeutics Stock Splits
There have been no stock splits for Acrivon Therapeutics (ACRV).
Acrivon Therapeutics Dividends
There have been no dividends for Acrivon Therapeutics (ACRV).